Free Trial

Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average - Here's Why

Northwest Biotherapeutics logo with Medical background

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report)'s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.26 and traded as low as $0.22. Northwest Biotherapeutics shares last traded at $0.22, with a volume of 3,307,507 shares.

Northwest Biotherapeutics Stock Performance

The stock has a market cap of $386.53 million, a P/E ratio of -3.79 and a beta of -1.12. The stock's fifty day simple moving average is $0.26 and its 200-day simple moving average is $0.26.

Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last posted its quarterly earnings data on Thursday, May 15th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.38 million for the quarter.

About Northwest Biotherapeutics

(Get Free Report)

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

See Also

Should You Invest $1,000 in Northwest Biotherapeutics Right Now?

Before you consider Northwest Biotherapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.

While Northwest Biotherapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines